LLY Operating cash flow
Operating cash flow at Lilly (Eli) rose to $16.8B in fiscal 2025, the highest in the 5 years reported, from $8.8B in 2024.
Net cash provided by operating activities, as filed.
SOURCE: us-gaap:NetCashProvidedByUsedInOperatingActivities · EDGAR CompanyFacts · CIK 59478 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Operating cash flow | Change |
|---|---|---|
| FY2025 | $16.8B | +$8.0B |
| FY2024 | $8.8B | +$4.6B |
| FY2023 | $4.2B | $-3.3B |
| FY2022 | $7.6B | +$220M |
| FY2021 | $7.4B | — |
Cross-checks touching this measure FROM THE FILING REVIEW
✓ MATCHESoperating cash flow
Every quoted figure reconciles to the filed lines: $16.8 billion against net cash provided by operating activities; $8.8 billion against net cash provided by operating activities.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANCash conversion stability
OCF ÷ NI ran 0.81× · 0.83× · 0.81× across three years — swing 0.02×, inside the 1.00× threshold.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANStock compensation in cash flow
Share-based compensation is 3.7% of operating cash flow (threshold 15%).
FY2025 10-K · FULL RECONCILIATION →More SAME DATA, OTHER VIEWS
Operating cash flow across coverage → · LLY company view →
Revenue · Net income · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.